Kazia Therapeutics Limited American Depositary Shares (KZIA) is a publicly traded Healthcare sector company. As of May 21, 2026, KZIA trades at $12.96 with a market cap of $143.52M and a P/E ratio of 0.00. KZIA moved +7.41% today. Year to date, KZIA is +126.75%; over the trailing twelve months it is +266.38%. Its 52-week range spans $2.86 to $39.05. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces KZIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Kazia Therapeutics Limited American Depositary Shares (KZIA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. KZIA moved +7.41% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $12.96 |
| Market Cap | $143.52M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.05 |
| 52-Week Low | $2.86 |
| Volume | 8 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover KZIA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.